Two Sigma Advisers’s Cardiol Therapeutics CRDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,500
| Closed | -$29.9K | – | 2484 |
|
|
2024
Q1 | $29.9K | Sell |
16,500
-400
| -2% | -$724 | ﹤0.01% | 2377 |
|
|
2023
Q4 | $14.3K | Hold |
16,900
| – | – | ﹤0.01% | 2457 |
|
|
2023
Q3 | $15.1K | Hold |
16,900
| – | – | ﹤0.01% | 2334 |
|
|
2023
Q2 | $15K | Sell |
16,900
-5,500
| -25% | -$4.9K | ﹤0.01% | 2335 |
|
|
2023
Q1 | $10.9K | Sell |
22,400
-13,500
| -38% | -$6.58K | ﹤0.01% | 2540 |
|
|
2022
Q4 | $18.3K | Hold |
35,900
| – | – | ﹤0.01% | 2433 |
|
|
2022
Q3 | $37K | Sell |
35,900
-26,600
| -43% | -$27.4K | ﹤0.01% | 2394 |
|
|
2022
Q2 | $83K | Sell |
62,500
-36,800
| -37% | -$48.9K | ﹤0.01% | 2412 |
|
|
2022
Q1 | $152K | Sell |
99,300
-24,300
| -20% | -$37.2K | ﹤0.01% | 2431 |
|
|
2021
Q4 | $229K | Buy |
123,600
+92,500
| +297% | +$171K | ﹤0.01% | 2238 |
|
|
2021
Q3 | $129K | Buy |
+31,100
| New | +$129K | ﹤0.01% | 2303 |
|